Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 5
1958 5
1959 8
1960 8
1961 6
1962 3
1963 11
1964 12
1965 11
1966 4
1967 6
1968 11
1969 8
1970 7
1971 12
1972 10
1973 12
1974 15
1975 16
1976 10
1977 12
1978 19
1979 14
1980 10
1981 15
1982 10
1983 19
1984 15
1985 13
1986 21
1987 22
1988 20
1989 31
1990 14
1991 14
1992 14
1993 15
1994 18
1995 17
1996 18
1997 27
1998 32
1999 26
2000 25
2001 25
2002 21
2003 31
2004 25
2005 29
2006 26
2007 35
2008 40
2009 39
2010 51
2011 39
2012 53
2013 45
2014 51
2015 53
2016 63
2017 59
2018 57
2019 44
2020 64
2021 63
2022 66
2023 54
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

1,510 results

Results by year

Filters applied: . Clear all
Page 1
The History of Psychedelics in Psychiatry.
Nichols DE, Walter H. Nichols DE, et al. Pharmacopsychiatry. 2021 Jul;54(4):151-166. doi: 10.1055/a-1310-3990. Epub 2020 Dec 7. Pharmacopsychiatry. 2021. PMID: 33285579
Initial interest in the value of psychedelic drugs ("psychotomimetics") in psychiatry began in the early 20(th) century, with explorations of the possibility that mescaline or peyote could produce psychosis-like effects. ...
Initial interest in the value of psychedelic drugs ("psychotomimetics") in psychiatry began in the early 20(th) century, with explora …
[Cannabidiol in cancer treatment].
Likar R, Köstenberger M, Nahler G. Likar R, et al. Schmerz. 2020 Apr;34(2):117-122. doi: 10.1007/s00482-019-00438-9. Schmerz. 2020. PMID: 31897700 Review. German.
In view of the status of tetrahydrocannabinol (THC) as a regulated substance, non-psychotomimetic cannabidiol (CBD) is of particular importance. OBJECTIVES: Efficacy of pure CBD in various animal models as well as initial results (case reports) from patients. ...
In view of the status of tetrahydrocannabinol (THC) as a regulated substance, non-psychotomimetic cannabidiol (CBD) is of particular …
Cannabinoids, reward processing, and psychosis.
Gunasekera B, Diederen K, Bhattacharyya S. Gunasekera B, et al. Psychopharmacology (Berl). 2022 May;239(5):1157-1177. doi: 10.1007/s00213-021-05801-2. Epub 2021 Mar 1. Psychopharmacology (Berl). 2022. PMID: 33644820 Free PMC article. Review.
BACKGROUND: Evidence suggests that an overlap exists between the neurobiology of psychotic disorders and the effects of cannabinoids on neurocognitive and neurochemical substrates involved in reward processing. AIMS: We investigate whether the psychotomimetic effects of de …
BACKGROUND: Evidence suggests that an overlap exists between the neurobiology of psychotic disorders and the effects of cannabinoids on neur …
A Brief Historical Overview of Psychedelic Research.
Geyer MA. Geyer MA. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May;9(5):464-471. doi: 10.1016/j.bpsc.2023.11.003. Epub 2023 Nov 23. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 38000715 Review.
Early hypotheses that serotonergic systems mediate psychedelic effects were supported initially by preclinical animal studies and subsequently confirmed by pharmacological studies in healthy humans. The use of psychedelic compounds as putative psychotomimetics that reprodu …
Early hypotheses that serotonergic systems mediate psychedelic effects were supported initially by preclinical animal studies and subsequent …
Psychotomimetic agents.
Cohen S. Cohen S. Annu Rev Pharmacol. 1967;7:301-18. doi: 10.1146/annurev.pa.07.040167.001505. Annu Rev Pharmacol. 1967. PMID: 5337083 Review. No abstract available.
Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
Černe K. Černe K. Arh Hig Rada Toksikol. 2020 Mar 1;71(1):1-11. doi: 10.2478/aiht-2020-71-3301. Arh Hig Rada Toksikol. 2020. PMID: 32597140 Free PMC article. Review.
THC is a partial agonist at both cannabinoid receptors, but its psychotomimetic effect is produced primarily via activation of the CB1 receptor, which is strongly expressed in the central nervous system, with the noteworthy exception of the brain stem. ...Unlike THC, phyto …
THC is a partial agonist at both cannabinoid receptors, but its psychotomimetic effect is produced primarily via activation of the CB …
A continuum hypothesis of psychotomimetic rapid antidepressants.
Haarsma J, Harmer CJ, Tamm S. Haarsma J, et al. Brain Neurosci Adv. 2021 May 3;5:23982128211007772. doi: 10.1177/23982128211007772. eCollection 2021 Jan-Dec. Brain Neurosci Adv. 2021. PMID: 34017922 Free PMC article. Review.
Ketamine, classical psychedelics and sleep deprivation are associated with rapid effects on depression. Interestingly, these interventions also have common psychotomimetic actions, mirroring aspects of psychosis such as an altered sense of self, perceptual distortions and …
Ketamine, classical psychedelics and sleep deprivation are associated with rapid effects on depression. Interestingly, these interventions a …
Neoclerodanes as atypical opioid receptor ligands.
Prisinzano TE. Prisinzano TE. J Med Chem. 2013 May 9;56(9):3435-43. doi: 10.1021/jm400388u. Epub 2013 Apr 18. J Med Chem. 2013. PMID: 23548164 Free PMC article. Review.
These effects are particularly remarkable because (1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist and (2) its effects are not mediated through the previously investigated targets of psychotomimetics. This Perspective outlines our research pro …
These effects are particularly remarkable because (1) salvinorin A is the first reported non-nitrogenous opioid receptor agonist and (2) its …
1,510 results